ERBB3 based methods and compositions for treating neoplasms

Details for Australian Patent Application No. 2003218600 (hide)

Owner Zensun (Shanghai) Sci-Tech. Ltd.

Inventors Zhou, Mingdong

Agent Pizzeys

Pub. Number AU-B-2003218600

PCT Number PCT/CN03/00217

PCT Pub. Number WO2003/080835

Priority 02 1 16259.x 26.03.02 CN

Filing date 26 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 21 May 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 02 1 16259.x 26.03.02 CN

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003218600

21 May 2009 Application Accepted

  Published as AU-B-2003218600

13 August 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Jul 2009. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden ACT 2606

17 December 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Jul 2009

17 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218601-PHOX2B POLYMORPHISMS AS HIRSCHSPRUNG'S DISEASE DIAGNOSTIC MARKERS AND METHODS BASED THEREON

2003218599-INTEGRATED PLATFORM FOR PASSIVE OPTICAL ALIGNMENT OF SEMICONDUCTOR DEVICE WITH OPTICAL FIBER